{"disease":{"id":"extranodal-nk-t-cell-lymphoma-nasal-and-nasal-type","name":"extranodal nk t cell lymphoma nasal and nasal type"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05907447","title":"A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT02085655","title":"PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":264,"lead_sponsor_name":"Huiqiang Huang","has_results":false},{"nct_id":"NCT05254899","title":"Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":54,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT05149170","title":"Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}